In tumor-like, lactate-rich hypoxic environments, the stabilization of lactylated HIF-1α may potentiate glycolytic and prosurvival gene programs (e.g., VEGF and GLUT1), thereby enhancing metabolic adaptation, cell survival, and chemoresistance [43, 44]. The gene discussed is VEGFA; the disease is neoplasm.